BUZZ-IDEXX shares rise after raising annual profit and revenue forecasts

Latest Updates

November 2 - ** Veterinary diagnostic device manufacturer IDEXX Laboratories (IDXX.O) shares rose 16.6% to $642.8

** If the rally holds, the stock is set for its biggest single-day gain since August 2025

** The company raised its fiscal 2026 revenue forecast to the range of $4.74 billion to $4.76 billion, up from its earlier forecast of $47 billion to $47.4 billion

** It raised its fiscal 2026 earnings per share (EPS) forecast range from $14.69–$14.94 to $14.96–$15.16

** Strong performance was mainly driven by an 11% revenue increase in its Companion Animal business segment and robust same-store sales

** Third-quarter (link) revenue came in at $1.21 billion, beating analysts' expectations of $1.19 billion — data compiled by LSEG

** Of 15 brokers, 9 assigned the stock a “buy” or higher rating, and 6 rated it “hold”; the median target price is $707.50 — LSEG data

** As of the previous trading day’s close, the stock was down 5.7% for the year

(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for reader convenience. Reuters bears no responsibility for any harm or loss arising from the use of the automated translation feature.)